Harel Insurance Investments & Financial Services’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-460
| Closed | -$3K | – | 733 |
|
|
2022
Q1 | $3K | Sell |
460
-59
| -11% | -$385 | ﹤0.01% | 678 |
|
|
2021
Q4 | $3K | Buy |
+519
| New | +$3K | ﹤0.01% | 719 |
|
|
2017
Q1 | – | Sell |
-8
| Closed | – | – | 436 |
|
|
2016
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 386 |
|
|
2016
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 523 |
|
|
2016
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 694 |
|